Skip to content
MARKETS / RSCF
LABORATORY APPARATUS & FURNITURE · SMALL CAP

Reflect Scientific, Inc. RSCF

14 fiscal years on record · USD · FY2023 reported · SEC filings only
$1.1M
▼ 47.1% YoY
$-459,028
▼ 613.5% YoY
In brief

What this company does

The company's growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers and refrigerated transportation in addition to supplying OEM products to the life sciences industry. Reflect Scientific designs, develops and sells scientific equipment for the life sciences and manufacturing industries. The company's Cryometrix ultra-low temperature and blast freezers are, it believes, a technological breakthrough that provides energy savings and other critically important benefits to cryo-storage customers in the life science related industries. In addition to its Cryometrix freezers, the company markets its Visacon OEM products, LCGCVials.com vial products, GCFerules.com OEM GC consumable products, and HPLC Detectors.com UV detector products into the chromatography market. As of March 26, 2024, subsequent to the balance sheet date, the company had 7 full-time and 1 part-time employees.

Written from the business description in Reflect Scientific, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 29 March 2024. Every sentence was checked against that document before publication.

Growth
USD 1.1M
Revenue, FY2023 · full 14-year series below
Revenue $M Net income $M
FY2023 · Revenue 1.1 · Net income -0.5
1.0M2.0M-0.8M-1.6M20102012201420162018202020222023
Compound annual growth
−27.1%
−7.0%
−1.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −7.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−42 cents
lost on every revenue dollar
Operating margin Net margin
FY2023 · Operating -43.3% · Net -42.5%
50%-100%-200%20102012201420162018202020222023
ROE
FY2023 · ROE -21.9%
-1000%-2000%20102012201420162018202020222023

Each USD of equity lost 22 cents this year.

Cash & shareholders
returned in FY2023 · dividends + net buybacks

Total assetsUSD 2.7M
EquityUSD 1.9M
CashUSD 1.3M
Current ratio3.97×

Equity funds 71% of total assets.

The 14-year record
14 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 20232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.00.00.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B···0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.0··0.00.00.00.00.00.00.00.00.00.0
Net income $B−0.00.00.00.0−0.0−0.0−0.0−0.00.0−0.0−0.00.0−0.0−0.0
EPS, diluted $−0.010.000.010.010.000.00−0.010.000.01−0.02−0.020.00−0.03·
Dividend / sh $··············
Payout %··············
ROE %−21.94.055.474.8−35.4−46.6−82.7−42.8····−2656.1−136.0
Shares out B0.090.090.080.080.080.080.070.070.060.060.050.050.040.03

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 1 failures in 64 reconciliationsAUDITED

Reconciled in 14 of 19 fiscal years. 31 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente1 failures
ActivityLaboratory Apparatus & Furniture
Listed onnot stated in the filings
Incorporated inUtah
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2009

Share this section

Download image